• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by AptarGroup Inc. (Amendment)

    2/10/22 10:35:47 AM ET
    $ATR
    Plastic Products
    Industrials
    Get the next $ATR alert in real time by email
    SC 13G/A 1 AptarGroup.txt MS AMENDMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.7)* APTARGROUP INC ----------------------------------------------------- (Name of Issuer) Common Stock ----------------------------------------------------- (Title of Class of Securities) 038336103 ----------------------------------------------------- (CUSIP Number) December 31, 2021 ----------------------------------------------------- (Date Of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1745 (3-06) CUSIP No.038336103 13G Page 2 of 5 Pages -------------------------------------------------------------------------------- 1. NAME OF REPORTING PERSON: I.R.S. IDENTIFICATION NO. OF ABOVE PERSON: Morgan Stanley I.R.S. # 36-3145972 -------------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP: (a) [ ] (b) [ ] -------------------------------------------------------------------------------- 3. SEC USE ONLY: -------------------------------------------------------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION: Delaware. -------------------------------------------------------------------------------- NUMBER OF 5. SOLE VOTING POWER: SHARES 0 BENEFICIALLY -------------------------------------------------------------- OWNED BY 6. SHARED VOTING POWER: EACH 3,637,007 REPORTING -------------------------------------------------------------- PERSON 7. SOLE DISPOSITIVE POWER: WITH: 0 -------------------------------------------------------------- 8. SHARED DISPOSITIVE POWER: 3,701,634 -------------------------------------------------------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON: 3,701,634 -------------------------------------------------------------------------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES: [ ] -------------------------------------------------------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9): 5.6% -------------------------------------------------------------------------------- 12. TYPE OF REPORTING PERSON: HC, CO -------------------------------------------------------------------------------- CUSIP No.038336103 13G Page 3 of 5 Pages -------------------------------------------------------------------------------- Item 1. (a) Name of Issuer: APTARGROUP INC -------------------------------------------------------------- (b) Address of Issuer's Principal Executive Offices: 475 W TERRA COTTA AVE STE E CRYSTAL LAKE IL 60014 UNITED STATES OF AMERICA -------------------------------------------------------------- Item 2. (a) Name of Person Filing: (1) Morgan Stanley -------------------------------------------------------------- (b) Address of Principal Business Office, or if None, Residence: (1) 1585 Broadway New York, NY 10036 -------------------------------------------------------------- (c) Citizenship: (1) Delaware. -------------------------------------------------------------- (d) Title of Class of Securities: Common Stock -------------------------------------------------------------- (e) CUSIP Number: 038336103 -------------------------------------------------------------- Item 3. If this statement is filed pursuant to Sections 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) [ ] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o). (b) [ ] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c). (c) [ ] Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c). (d) [ ] Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). (e) [ ] An investment adviser in accordance with Sections 240.13d-1(b)(1)(ii)(E); (f) [ ] An employee benefit plan or endowment fund in accordance with Section 240.13d-1(b)(1)(ii)(F); (g) [x] A parent holding company or control person in accordance with Section 240.13d-1(b)(1)(ii)(G); (h) [ ] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) [ ] A non-U.S. institution in accordance with section 240.13d-1(b)(1)(ii)(J); (k) [ ] Group, in accordance with sections 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with sections 240.13d-1(b)(1)(ii)(J), please specify the type of institution: Not Applicable CUSIP No.038336103 13G Page 4 of 5 Pages -------------------------------------------------------------------------------- Item 4. Ownership as of December 31, 2021.* (a) Amount beneficially owned: See the response(s) to Item 9 on the attached cover page(s). (b) Percent of Class: See the response(s) to Item 11 on the attached cover page(s). (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote: See the response(s) to Item 5 on the attached cover page(s). (ii) Shared power to vote or to direct the vote: See the response(s) to Item 6 on the attached cover page(s). (iii) Sole power to dispose or to direct the disposition of: See the response(s) to Item 7 on the attached cover page(s). (iv) Shared power to dispose or to direct the disposition of: See the response(s) to Item 8 on the attached cover page(s). Item 5. Ownership of Five Percent or Less of a Class. Not Applicable Item 6. Ownership of More Than Five Percent on Behalf of Another Person. Not Applicable Item 7. Identification and Classification of the Subsidiary which Acquired the Security Being Reported on By the Parent Holding Company. Not Applicable Item 8. Identification and Classification of Members of the Group. Not Applicable Item 9. Notice of Dissolution of Group. Not Applicable Item 10. Certification. (1) By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. * In Accordance with the Securities and Exchange Commission Release No. 34-39538 (January 12, 1998) (the "Release"), this filing reflects the securities beneficially owned, or that may be deemed to be beneficially owned, by certain operating units (collectively, the "MS Reporting Units") of Morgan Stanley and its subsidiaries and affiliates (collectively, "MS"). This filing does not reflect securities, if any, beneficially owned by any operating units of MS whose ownership of securities is disaggregated from that of the MS Reporting Units in accordance with the Release. CUSIP No.038336103 13G Page 5 of 5 Pages -------------------------------------------------------------------------------- Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: February 10, 2022 Signature: /s/ Christopher O'Hara -------------------------------------------------------------------- Name/Title: Christopher O'Hara/Authorized Signatory, Morgan Stanley -------------------------------------------------------------------- MORGAN STANLEY
    Get the next $ATR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ATR

    DatePrice TargetRatingAnalyst
    3/20/2026$144.00Equal Weight → Overweight
    Wells Fargo
    1/6/2026$133.00Overweight → Equal Weight
    Wells Fargo
    11/3/2025Outperform → Mkt Perform
    William Blair
    9/4/2025$220.00Overweight
    KeyBanc Capital Markets
    1/7/2025$200.00Outperform
    Raymond James
    1/6/2025$173.00Buy → Neutral
    BofA Securities
    10/14/2024$155.00 → $215.00Hold → Buy
    Jefferies
    4/29/2024Mkt Perform → Outperform
    William Blair
    More analyst ratings

    $ATR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    AptarGroup upgraded by Wells Fargo with a new price target

    Wells Fargo upgraded AptarGroup from Equal Weight to Overweight and set a new price target of $144.00

    3/20/26 8:27:39 AM ET
    $ATR
    Plastic Products
    Industrials

    AptarGroup downgraded by Wells Fargo with a new price target

    Wells Fargo downgraded AptarGroup from Overweight to Equal Weight and set a new price target of $133.00

    1/6/26 8:44:42 AM ET
    $ATR
    Plastic Products
    Industrials

    AptarGroup downgraded by William Blair

    William Blair downgraded AptarGroup from Outperform to Mkt Perform

    11/3/25 9:08:28 AM ET
    $ATR
    Plastic Products
    Industrials

    $ATR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Human Resources Officer Vinczeller Shiela sold $400,341 worth of shares (3,555 units at $112.61), decreasing direct ownership by 12% to 27,078 units (SEC Form 4)

    4 - APTARGROUP, INC. (0000896622) (Issuer)

    6/5/26 4:15:25 PM ET
    $ATR
    Plastic Products
    Industrials

    President, Asia Gong Xiangwei sold $487,765 worth of shares (4,200 units at $116.13), decreasing direct ownership by 28% to 10,774 units (SEC Form 4)

    4 - APTARGROUP, INC. (0000896622) (Issuer)

    5/27/26 3:31:43 PM ET
    $ATR
    Plastic Products
    Industrials

    Segment President Tlili Hedi covered exercise/tax liability with 688 shares, decreasing direct ownership by 3% to 24,233 units (SEC Form 4)

    4 - APTARGROUP, INC. (0000896622) (Issuer)

    5/21/26 4:21:07 PM ET
    $ATR
    Plastic Products
    Industrials

    $ATR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Aptar Named a CDP Supplier Engagement Leader for the Sixth Consecutive Year

    Recognized for Continued Supply Chain Collaboration AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, was named a CDP Supplier Engagement Leader, for the sixth consecutive year. This assessment, based on information reported within the 2025 CDP reporting cycle, highlights companies that are engaging their suppliers on climate change and supporting efforts to address emissions throughout the value chain. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260602301467/en/Aptar is Named a CDP Supplier Engagement Leader for the Sixth Consecutive Year By

    6/2/26 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    Aptar to Participate in Upcoming Investor Conferences

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that it will present at two upcoming investor conferences: Jefferies Global Healthcare Conference in New York, NY on Wednesday, June 3, 2026. Vanessa Kanu, Executive Vice President and CFO, will present at 12:45 p.m. Eastern Standard Time. Wells Fargo Industrials and Materials Conference in Chicago, IL on Tuesday, June 9, 2026. Vanessa Kanu, Executive Vice President and CFO, will present at 1:45 p.m. Eastern Standard Time. A live audio webcast and presentation materials will be available in the "Investors" section of the Company's websi

    5/27/26 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    Aptar Advances Sustainability Features in Luxury Packaging through Patented Reloadable Airless Innovation with Clarins

    Innovation wins 2026 DIELINE Award with Clarins Total Eye Lift for ‘Sustainable Design – Health, Body & Beauty' AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today highlighted how its patented, high performance airless dispensing innovation is enabling prestige beauty brands to advance sustainability without compromising performance or luxury. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260506201869/en/Aptar Advances Sustainability Features in Luxury Packaging through Patented Reloadable Airless Innovation with Clarins. Through a long‑stan

    5/6/26 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    $ATR
    SEC Filings

    View All

    SEC Form SD filed by AptarGroup Inc.

    SD - APTARGROUP, INC. (0000896622) (Filer)

    5/18/26 1:07:39 PM ET
    $ATR
    Plastic Products
    Industrials

    AptarGroup Inc. filed SEC Form 8-K: Leadership Update

    8-K - APTARGROUP, INC. (0000896622) (Filer)

    5/13/26 7:00:54 AM ET
    $ATR
    Plastic Products
    Industrials

    SEC Form 8-K filed by AptarGroup Inc.

    8-K - APTARGROUP, INC. (0000896622) (Filer)

    5/7/26 4:01:47 PM ET
    $ATR
    Plastic Products
    Industrials

    $ATR
    Leadership Updates

    Live Leadership Updates

    View All

    Aptar Announces Gael Touya as its Next Chief Executive Officer; Stephan B. Tanda to Retire by the End of the Year

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that Gael Touya, a seasoned global executive with more than 30 years of experience at the company, most recently as Aptar Pharma President, has been appointed President and Chief Executive Officer, effective September 1, 2026. He will succeed Stephan B. Tanda, who has served as President and Chief Executive Officer since 2017. Stephan is expected to continue to work closely with Gael and the Board as an advisor through the end of the year to help ensure a seamless transition as the company enters its next phase of growth. Stephan intends to reti

    3/17/26 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    Aptar CFO, Robert (Bob) Kuhn, Has Decided to Step Down After 37 Years with the Company

    Aptar Names Vanessa Kanu, A Finance Veteran with Over 25 Years of Experience, as Next CFO AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that Bob Kuhn, Executive Vice President and Chief Financial Officer (CFO) since 2008, has decided to retire at the end of this year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240725873916/en/(Left to right) Bob Kuhn, Executive Vice President and Chief Financial Officer since 2008, has decided to retire at the end of 2024; Vanessa Kanu will become Executive Vice President and CFO on January 1, 2025,

    7/25/24 5:20:00 PM ET
    $ATR
    Plastic Products
    Industrials

    Aptar Appoints Global Finance and Operations Veteran Sarah Glickman to its Board of Directors

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that Sarah Glickman, an accomplished leader with more than 30 years of global financial and operational experience, has joined its Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230905451175/en/Sarah Glickman Joins Aptar's Board of Directors (Photo: Aptar) "We are pleased to welcome Sarah Glickman to our Board of Directors. Sarah's extensive knowledge of all aspects of corporate finance coupled with her global operational experience, including in the pharmaceutical industry

    9/5/23 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    $ATR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by AptarGroup Inc. (Amendment)

    SC 13G/A - APTARGROUP, INC. (0000896622) (Subject)

    2/13/24 4:58:57 PM ET
    $ATR
    Plastic Products
    Industrials

    SEC Form SC 13G/A filed by AptarGroup Inc. (Amendment)

    SC 13G/A - APTARGROUP, INC. (0000896622) (Subject)

    2/12/24 3:08:10 PM ET
    $ATR
    Plastic Products
    Industrials

    SEC Form SC 13G/A filed by AptarGroup Inc. (Amendment)

    SC 13G/A - APTARGROUP, INC. (0000896622) (Subject)

    2/12/24 11:53:37 AM ET
    $ATR
    Plastic Products
    Industrials

    $ATR
    Financials

    Live finance-specific insights

    View All

    Aptar Reports First Quarter 2026 Results

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today reported the following first quarter results for the period ended March 31, 2026, as compared to the corresponding period of the last fiscal year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430601030/en/Aptar Reports First Quarter 2026 Results First Quarter 2026 Highlights (Compared to the prior year quarter; see Non-GAAP section for full definitions; see reconciliation for Non-GAAP measures) Reported sales increased 11% and core sales were flat Reported net income decreased 8% t

    4/30/26 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    Aptar Declares Quarterly Dividend

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, including dosing and protection technologies, and consumer product dispensing, today announced that the Board declared a quarterly cash dividend of $0.48 per share. The payment date is May 27, 2026, to stockholders of record as of May 6, 2026. As previously announced, Aptar will hold a conference call on Friday, May 1, 2026, at 8:00 a.m. Central Time to discuss the Company's first quarter results for 2026. The call will last approximately one hour. Interested parties are invited to listen to a live webcast by visiting the Investors page at www.aptar.com. A replay of the conference call can also be accessed for a limited time o

    4/23/26 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    Aptar Reports Fourth Quarter and Annual 2025 Results

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today reported the following fourth quarter results for the period ended December 31, 2025, as compared to the corresponding period of the last fiscal year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260205227722/en/Photo: Aptar Fourth Quarter 2025 Highlights (Compared to the prior year quarter; see Non-GAAP section for full definitions; see reconciliation for Non-GAAP measures) Reported sales increased 14% and core sales increased 5%—all three segments delivered core sales growth Reporte

    2/5/26 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials